pharmaceuticals

JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q3 2025 financial results

October 14, 2025

IPO News: MapLight Therapeutics targets $704 mln valuation in Nasdaq debut

October 8, 2025

Innovation pipeline, portfolio in focus ahead of Johnson & Johnson’s Q3 earnings

October 3, 2025

McKesson Corporation (MCK) raises FY26 earnings guidance

September 24, 2025

Earnings Summary: Cardinal Health reports higher Q4 earnings and flat revenues

August 12, 2025

Key highlights from Eli Lilly’s (LLY) Q2 2025 earnings results

August 7, 2025

Eli Lilly (LLY) set to report Q2 2025 results. Here’s what to expect

August 5, 2025

PFE Earnings: All you need to know about Pfizer’s Q2 2025 earnings results

August 5, 2025

BIIB Earnings: Highlights of Biogen’s Q2 2025 results

July 31, 2025

Key highlights from AbbVie’s (ABBV) Q2 2025 earnings results

July 31, 2025

MRK Earnings: Merck & Co Q2 adj. profit drops on lower sales

July 29, 2025

Abbott Laboratories (ABT) Q2 2025 sales and earnings beat estimates

July 17, 2025

Key highlights from Johnson & Johnson’s (JNJ) Q2 2025 earnings results

July 16, 2025

Molina Healthcare reports preliminary Q2 2025 financial results

July 7, 2025

Plus Therapeutics CEO: Lead candidate REYOBIQ demonstrates strong safety and efficacy in early trials

June 9, 2025

Earnings Summary: Henry Schein (HSIC) reports higher Q1 2025 profit

May 5, 2025

Earnings Summary: Cigna Group (CI) reports 14% growth in Q1 2025 revenue

May 2, 2025

BIIB Earnings: Biogen Q1 2025 adj. profit drops despite higher revenues

May 1, 2025

Key highlights from Pfizer’s (PFE) Q1 2025 earnings results

April 29, 2025

AbbVie Q1 2025 adjusted earnings increase on 8% revenue growth; beat estimates

April 25, 2025

Bristol-Myers Squibb swings to profit in Q1 2025; revenue drops

April 24, 2025